급성 세균성 전립선염의 임상경과에 관한 다기관 연구
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이성주 | - |
dc.contributor.author | 심봉석 | - |
dc.contributor.author | 구진모 | - |
dc.contributor.author | 조용현 | - |
dc.contributor.author | 한창희 | - |
dc.contributor.author | 민권식 | - |
dc.contributor.author | 이선주 | - |
dc.contributor.author | 이상돈 | - |
dc.contributor.author | 김준모 | - |
dc.contributor.author | 최종보 | - |
dc.contributor.author | 김태형 | - |
dc.contributor.author | 양상국 | - |
dc.contributor.author | 이길호 | - |
dc.contributor.author | 나용길 | - |
dc.contributor.author | 이성호 | - |
dc.contributor.author | 정희종 | - |
dc.contributor.author | 정승일 | - |
dc.contributor.author | 김철성 | - |
dc.contributor.author | 정재민 | - |
dc.contributor.author | 서영진 | - |
dc.contributor.author | 조원열 | - |
dc.date.accessioned | 2021-08-12T06:26:53Z | - |
dc.date.available | 2021-08-12T06:26:53Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 2465-8243 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/17055 | - |
dc.description.abstract | Purpose: Proper guidelines concerning antibiotic administration for acute bacterial prostatitis (ABP) are unclear. We retrospectively analyzed treatment status and clinical outcomes to establish a proper treatment guideline. Materials and Methods: The clinical records of 669 patients from 21 hospitals diagnosed with ABP were reviewed. Prior manipulation, antibiotics administration, mean length of treatment, complication and procedure were analyzed. Results: The mean age of 538 patients (80.4%) without manipulation (group 1) and 131 patients (19.6%) with manipulation (group 2) was 58.3 years (range 19-88 years). Transrectal prostate biopsy was the most common cause of acute bacterial prostatitis (n=66; 50.4%). Of the clinical symptoms in the non-manipulation and manipulation groups, fever was most common (88.2% and 86.3%, respectively). Acute urinary retention (14.3% and 28.1%, respectively) was significantly increased in the manipulation group (p<0.05). Escherichia coli was the most frequently isolated bacterium from urine (72.0% and 66.7% of cases, respectively). Mean length of treatment was 6.5days and 7.9days, respectively; the difference was significant (p<0.05). Combination antibiotic therapy with third generation cephalosporin+aminoglycoside was used in 49.3% and 55.5% of cases, respectively. For single antibiotic therapy, second generation quinolones were used the most (35.5% and 34.3%, respectively). Sequale occurred in 29 group 1 patients (5.4%) and 20 group 2 patients (15.3%); the difference was significant (p<0.05). Conclusions: Prior manipulation was associated with 20% of ABP patients. Regardless of manipulation, clinical outcome was similar after treating with appropriate antibiotics. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한요로생식기감염학회 | - |
dc.title | 급성 세균성 전립선염의 임상경과에 관한 다기관 연구 | - |
dc.title.alternative | Clinical Outcome of Acute Bacterial Prostatitis; A Multicenter Study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 김준모 | - |
dc.identifier.bibliographicCitation | Urogenital Tract Infection, v.6, no.2, pp.165 - 170 | - |
dc.relation.isPartOf | Urogenital Tract Infection | - |
dc.citation.title | Urogenital Tract Infection | - |
dc.citation.volume | 6 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 165 | - |
dc.citation.endPage | 170 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001627553 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Anti-bacterial agents | - |
dc.subject.keywordAuthor | Prostatitis | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | Outcome | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.